Genetics of diabetic nephropathy and microalbuminuria

Borch-Johnsen K , Andersen PK , Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985; 28: 590–6.

Mogensen CE. How to protect the kidney in diabetic patients. With special reference to IDDM. Diabetes 1997; 46(suppl 2): S104–S111.

Parving HH , Hommel E. Prognosis in diabetic nephropathy. BMJ 1989; 299: 230–3.

Anderson AR , Christiansen IS , Anderson JK , Kreiner S , Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983; 25: 496–501.

Krolewski AS , Warram JH , Christlieb AR , Busick EJ , Kahn CR. The changing natural history of nephropathy in type 1 diabetes. Am J Med 1985; 78: 785–93.

Klein R , Klein BEK , Moss SE. The Wisconsin Epidemiologic study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 527–32.

Seaquist ER , Goetz FC , Rich S , Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161–5.

Borch-Johnsen K , Norgaard K , Hommel E. Is diabetic nephropathy an inherited complication? Kidney Int 1992; 41: 719–22.

Quinn M , Angelico MC , Warram JH , Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39: 940–5.

DCCT. Clustering of long term complications in families with diabetes in the Diabetes Control and Complications Trials. Diabetes 1997; 46: 1829–39.

Viberti GC , Keen H , Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. BMJ 1987; 295: 515–18.

Krolewski AS , Canessa H , Warram JH. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140–5.

Barzilay J , Warram JH , Bak M , Laffel LM , Canessa M , Krolewski AS. Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int 1992; 41: 723–30.

Roglic G , Colhoun HM , Stevens LK , Lemkes HH , Manes C , Fuller JH. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin dependent diabetes mellitus: the EURODIAB IDDM complications study. Diab Med 1998; 15: 418–27.

Earle K , Walker J , Hill C , Viberti G. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1992; 326: 673–7.

De Cosmo S , Bacci S , Piras GP. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia 1997; 40: 1191–6.

Groop L , Ekstrand A , Forsblom C. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Lancet 1996; 36: 642–7.

Yip J , Mattock MB , Morocutti A , Sethi M , Trevisan R , Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993; 342: 883–7.

Yip J , Mattock M , Sethi M , Morocutti A , Viberti G. Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria [Letter]. Lancet 1993; 341: 369–70.

Spielman RS , McGinnis RE , Ewens WJ. Transmission distortion test for linkage: the insulin gene and susceptibility to insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1992; 52: 506–16.

Barbosa J , Saner B. Do genetics factors play a role in the pathogenesis of diabetic microangiopathy? Diabetologia 1984; 27: 487–92.

Pyke D , Tattersall R. Diabetic retinopathy in identical twins. Diabetes 1973; 22: 613–18.

Chowdhury TA , Dyer PH , Mijovic CH , Dunger D , Barnett AH , Bain SC. HLA and insulin genes in diabetic nephropathy. Diabetologia 1999; 42: 1017–20.

Hallab M , Bled F , Ebran JM. Elevated serum angiotensin converting enzyme activity in type 1, insulin dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol 1992; 29: 82–5.

Rigat B , Hubert C , Alhenc-Gelas F , Cambien F , Corvol P , Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343–6.

Doria A , Warram JH , Krolewski AS. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690–5.

Marre M , Bernadet P , Gallois Y. Relationships between angiotensin I converting enzyme gene polymorphism plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43: 348–8.

Schmidt S , Schone N , Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int 1995; 47: 1176–81.

Tarnow L , Cambien F , Rossing P. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489–94.

Chowdhury TA , Dronsfield MJ , Kumar S. Examination of two genetic polymorphisms within the renin—angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 1996; 39: 1108–14.

Parving HH , Jacobsen P , Tarnow L. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. BMJ 1996; 313: 591–4.

Penno G , Chaturvedi N , Talmud PJ. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients. Diabetes 1998; 47: 1507–11.

van Essen GG , Rensma PL , de Zeeuw D. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996; 347: 94–5.

Caulfield M , Lavender P , Farrall M. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1629–33.

Fogarty DG , Harron JC , Hughes AE , Nevin NC , Doherty CC , Maxwell AP. A molecular variant of Angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996; 45: 1204–8.

Schmidt S , Giessel R , Bergis KH. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group. Nephrol Dial Trans 1996; 11: 1755–61.

Tarnow L , Cambien F , Rossing P. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996; 45: 367–9.

Bonnardeaux A , Davies E , Jeunemaitre X. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24: 63–9.

Chowdhury TA , Dyer PH , Kumar S. Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus. Diabetic Med 1997; 14: 837–40.

Tarnow L , Cambien F , Rossing P. Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy. Nephrol Dial Transplant 1996; 11: 1019–23.

Heesom AE , Hibberd ML , Millward A , Demaine AG. Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes 1997; 46: 287–91.

Dyer PH , Chowdhury TA , Dronsfield MJ , Dunger D , Barnett AH , Bain SC. The 5′-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian Type I diabetic patients [Letter]. Diabetologia 1999; 42: 1030.

Moczulski DK , Burak W , Zynchma M , Szczechowska EZ , Warram JH , Grzeszczak W. Role of aldose reductase gene in susceptibility to diabetic nephropathy in NIDDM [Abstract]. Diabetes 1998; 47(suppl 1): A52.

Deckert T , Feldt Rasmussen B , Borch-Johnsen K , Jensen T , Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno Hypothesis. Diabetologia 1989; 32: 219–26.

Hansen PM , Chowdhury TA , Deckert T , Hellgren A , Bain SC , Pociot F. Genetic variation of the heparan sulphate proteoglycan gene (perlecan gene). Association with albumin excretion in IDDM patients. Diabetes 1997; 46: 1658–9.

Chowdhury TA , Dyer PH , Kumar S. Association of apolipoprotein e2 allele with diabetic nephropathy in subjects with insulin dependent diabetes mellitus. Diabetes 1998; 47: 278–81.